Management of Skin and Soft Tissue Infections in Community Practice Before and After Implementing a “Best Practice” Approach: An Iowa Research Network (IRENE) Intervention Study

References

1. 1.↵
   1. Kaplan SL,
   2. Hulten KG,
   3. Gonzalez BE,
   4. et al

   . Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infect Dis 2005;40:1785–91.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   Centers for Disease Control and Prevention. Outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections: Los Angeles County, California, 2002–2003. MMWR-Morb Mortal Wkly Rep 2003;52:88.

   OpenUrl
3. 3.↵
   1. Hersh AL,
   2. Chambers HF,
   3. Maselli JH,
   4. Gonzales R

   . National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections. Arch Intern Med 2008;168:1585–91.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Moran GJ,
   2. Krishnadasan A,
   3. Gorwitz RJ,
   4. et al

   . Methicillin-resistant S aureus infections among patients in the emergency department. N Engl J Med 2006;355:666–74.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   1. Parchman ML,
   2. Munoz A

   . Risk factors for methicillin-resistant Staphylococcal aureus skin and soft tissue infections presenting in primary care: a South Texas Ambulatory Research Network (STARNet) study. J Am Board Fam Med 2009;22:375–9.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   1. Szumowski JD,
   2. Cohen DE,
   3. Kanaya F,
   4. Mayer KH

   . Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic. Antimicrob Agents Chemother 2007;51:423–8.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. King MD,
   2. Humphrey BJ,
   3. Wang YF,
   4. et al

   . Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann Intern Med 2006;144:309–17.

   OpenUrlCrossRefPubMedWeb of Science
8. 8.↵
   1. Chen AE,
   2. Goldstein M,
   3. Carroll K,
   4. et al

   . Evolving epidemiology of pediatric Staphylococcus aureus cutaneous infections in a Baltimore hospital. Pediatr Emerg Care 2006;22:717–23.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Klevens RM,
   2. Morrison MS,
   3. Nadle J,
   4. et al

   . Invasive methicillin-resistant staphylococcus aureus infections in the United States. JAMA 2007;209:1763–71.

   OpenUrl
10. 10.↵
    1. Lawrence KR,
    2. Golik MV,
    3. Davidson L

    . The role of primary care prescribers in the diagnosis and management of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections. Am J Ther 2009;16:333–8.

    OpenUrlCrossRefPubMedWeb of Science
11. 11.↵
    1. Gonzalez BE,
    2. Martinez-Aguilar G,
    3. et al

    . Severe Staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus. Pediatrics 2005;115:642–8.

    OpenUrlAbstract/FREE Full Text
12. 12.↵
    1. Francis JS,
    2. Doherty MC,
    3. Lopatin U,
    4. et al

    . Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis 2005;40:100–107.

    OpenUrlAbstract/FREE Full Text
13. 13.↵
    1. Mold JW,
    2. Gregory ME

    . Best practices research. Fam Med 2003;35:131–134.

    OpenUrlPubMed
14. 14.↵
    1. Daly JM,
    2. Ely JW,
    3. Levy BT,
    4. et al

    . Family physicians' perspectives on management of skin and soft tissue infections: an Iowa Research Network study. J Rural Health 2010;27:319–328.

    OpenUrlPubMed
15. 15.↵
    Centers for Disease Control and Prevention. Outpatient management of MRSA skin and soft tissue infections. http://www.cdc.gov/mrsa/treatment/outpatient-management.html. Updated August 9, 2010. Accessed June 26, 2008.
16. 16.↵
    1. Lowy FD,
    2. Sexton DJ,
    3. Baron EL

    . Treatment of skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus in adults. Waltham, MA: UpToDate; 2008.
17. 17.↵
    American Academy of Family Physicians. MRSA: (Methicillin-resistant Staphylococcus aureus). http://familydoctor.org/online/famdocen/home/common/infections/common/bacterial/926.html. Updated May, 2010. Accessed June 26, 2008.
18. 18.↵
    American Academy of Family Physicians. First aid: cuts, scrapes, and stitches. http://familydoctor.org/online/famdocen/home/healthy/firstaid/after-injury/041.html. Updated December, 2010. Accessed June 26, 2008.
19. 19.↵
    1. Arnold FW,
    2. Wojda B

    . An analysis of a community-acquired pathogen in a Kentucky community: methicillin-resistant Staphylococcus aureus. J Ky Med Assoc 2005;103:206–10.

    OpenUrlPubMed
20. 20.↵
    1. Benjamin HJ,
    2. Nikore V,
    3. Takagishi J

    . Practical management: community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA): the latest sports epidemic. Clin J Sport Med 2007;17:393–7.

    OpenUrlCrossRefPubMed
21. 21.↵
    1. Polgreen PM,
    2. Herwaldt LA

    . Staphylococcus aureus colonization and nosocomial infections: implications for prevention. Curr Infect Dis Rep 2004;6:435–41.

    OpenUrlPubMed
22. 22.↵
    Centers for Disease Control and Prevention. Community-associated methicillin resistant Staphylococcus aureus (CA-MRSA). http://www.cdc.gov/mrsa/index.html. Updated April 5, 2011. Accessed August 27, 2010.
23. 23.↵
    1. Ruhe JJ,
    2. Smith N,
    3. Bradsher RW,
    4. Menon A

    . Community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: impact of antimicrobial therapy on outcome. Clin Infect Dis 2007;44:777–84.

    OpenUrlAbstract/FREE Full Text
24. 24.↵
    1. Hart AC,
    2. Stegman MS,
    3. Ford B

    , eds. ICD-9-CM Expert for Physicians, Vol 1–2: International Classification of Diseases, 9th Revision: Clinical Modification. 6th edition. Salt Lake City, UT: Ingenix; 2009.
25. 25.↵
    U.S. Department of Agriculture. Measuring rurality: rural-urban continuum codes. http://www.ers.usda.gov/briefing/rurality/. Updated August 17, 2010. Accessed July 30, 2010.
26. 26.↵
    1. Grimshaw JM,
    2. Russell IT

    . Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 1993;342:1317–22.

    OpenUrlCrossRefPubMedWeb of Science
27. 27.↵
    1. Davis DA,
    2. Taylor-Vaisey A

    . Translating guidelines into practice: a systematic review of theoretic concepts, practical experience and research evidence in the adoption of clinical practice guidelines. CMAJ 1997;157:408–16.

    OpenUrlAbstract/FREE Full Text
28. 28.↵
    1. Grimshaw JM,
    2. Thomas RE,
    3. MacLennan G,
    4. et al

    . Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess 2004;8:1–72.

    OpenUrlPubMed
29. 29.↵
    1. Naughton C,
    2. Feely J,
    3. Bennett K

    . An RCT evaluating the effectiveness and cost-effectiveness of academic detailing versus postal prescribing feedback in changing GP antibiotic prescribing. J Eval Clin Pract 2009;15:807–12.

    OpenUrlCrossRefPubMedWeb of Science
30. 30.↵
    1. Shankar PR,
    2. Jha N,
    3. Piryani RM,
    4. et al

    . Academic detailing. Kathmandu Univ Med J 2010;8:126–34.

    OpenUrl
31. 31.↵
    1. Lee MC,
    2. Rios AM,
    3. Aten MF,
    4. et al

    . Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus. Pediatr Infect Dis J 2004;23:123–7.

    OpenUrlCrossRefPubMedWeb of Science